Pfizer's stock has risen off its lows, but remains 50% below its 2021 highs.
Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 ...
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
The FDA has started accepting requests to participate in its PreCheck pilot programme, designed to make it easier and quicker ...
Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...
Karen West is devastated her son Joshua West’s seizure medication has been discontinued. Picture: Russell Millard “We had ...
Press Trust of India on MSN
Rs 10,000-cr 'Biopharma Shakti' an investment in India’s health, innovation future: Industry
New Delhi, Feb 1 (PTI) The government has made a decisive investment in the country’s health and innovation future by proposing an outlay of Rs 10,000 crore in the budget for the development of the ...
The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, ...
Regulation, technology and buyer skepticism are pushing historically opaque industries toward radical transparency, and it’s great for everyone.
Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids.
WASHINGTON, DC – US lawmakers renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid-19 pandemic by India ...
The U.S. has no good backup plan if major overseas suppliers decide to stop selling prescription drugs or their raw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results